Journal of Endocrinological Investigation

, Volume 26, Issue 8, pp 723–727 | Cite as

Ghrelin secretion in severely obese subjects before and after a 3-week integrated body mass reduction program

  • P. S. Morpurgo
  • M. Resnik
  • F. Agosti
  • V. Cappiello
  • A. Sartorio
  • A. SpadaEmail author
Original Article


Ghrelin, the endogenous ligand of GH-secretagogue receptors, has been implicated in the regulation of feeding behavior and energy balance. Aim of the study was to investigate ghrelin levels in fasting conditions and after a standard meal test in obese subjects before and after a 3-week integrated body weight reduction (BWR) program (consisting of energyrestricted diet, exercise training, psychological counselling and nutritional education). Weight, height, fat mass, fat free mass (by impedentiometry), circulating ghrelin, insulin and leptin levels were evaluated in 10 obese subjects (3 male, 7 female; mean age: 35±9.3 yr; body mass index BMI: 45.2±10.6 kg/m2) before and after weight reduction. At baseline, obese subjects showed significantly lower ghrelin levels than controls, which were negatively correlated with BMI, weight, insulin and leptin levels. Fasting ghrelin levels were not modified by standard meal test in obese subjects (from 110.8±69.7 to 91.8±70.2 pmol/l p=ns), while a significant reduction was observed in controls (from 352.4±176.7 to 199.0±105.2 pmol/l; p<0.01). After a 3-week integrated BWR program obese subjects significantly reduced weight, BMI and leptin levels, while no significant changes were found both in fasting ghrelin and in ghrelin response after the meal. In conclusion, 5% weight loss obtained after a short-term period of integrated BWR program is not sufficient to normalize fasting ghrelin levels nor to restore the normal ghrelin suppression after a meal in severely obese subjects.


Ghrelin obesity meal test 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001, 12: 118–22.PubMedCrossRefGoogle Scholar
  2. 2.
    Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000, 141: 4325–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000, 407: 908–13.PubMedCrossRefGoogle Scholar
  4. 4.
    Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001, 86: 5992–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Caixas A, Bashore C, Nash W, Pi-Sunyer FX, Laferrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 2002, 87: 1902–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Cappiello V, Ronchi C, Morpurgo PS, et al. Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur J Endocrinol 2002, 147: 189–94.PubMedCrossRefGoogle Scholar
  7. 7.
    Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002, 87: 240–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Cummings DE, Purnell JQ, Frayo RQ, Schidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50: 1714–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50: 707–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Otto B, Cuntz U, Fruehauf E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001, 145: R5–9.Google Scholar
  11. 11.
    Tanaka M, Naruo T, Muranaga T, et al. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol 2002, 146: R1–3.PubMedCrossRefGoogle Scholar
  12. 12.
    English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JPH. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 2002, 87: 2984–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Ravussin E, Tschop M, Morales S, Bouchard C, Heiman ML. Plasma ghrelin concentration and energy balance: overfeeding and negative energy balance studies in twins. J Clin Endocrinol Metab 2001, 86: 4547–51.PubMedCrossRefGoogle Scholar
  14. 14.
    Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002, 346: 1623–30.PubMedCrossRefGoogle Scholar
  15. 15.
    Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 2002, 56: 203–6.CrossRefGoogle Scholar
  16. 16.
    Sartorio A, Lafortuna CL, Conte G, Faglia G, Narici MV. Changes in motor control and muscle performance after a short-term body mass reduction program in obese subjects. J Endocrinol Invest 2001, 24: 393–8.PubMedGoogle Scholar
  17. 17.
    Sartorio A, Lafortuna CL, Vangeli V, Tavani A, Bosetti C, La Vecchia C. Short-term changes of cardiovascular risk factors after a non-pharmacological body weight reduction program. Eur J Clin Nutr 2001, 55: 865–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Deurenberg P. International consensus conference on impedance in body composition. Age Nutr 1994, 5: 142–5.Google Scholar
  19. 19.
    Woods SC, Seeley RJ, Porte D Jr, Schwartz MW. Signals that regulate food intake and energy homeostasis. Nature 1998, 280: 1378–83.Google Scholar
  20. 20.
    Lee HM, Wang G, Englander EW, Kojima M, Greeley GH Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002, 143: 185–90.PubMedCrossRefGoogle Scholar
  21. 21.
    Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996, 81: 3419–23.PubMedGoogle Scholar
  22. 22.
    Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR, Kuijper JL. Effect of fasting, refeeding and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 1997, 82: 561–5.PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2003

Authors and Affiliations

  • P. S. Morpurgo
    • 1
  • M. Resnik
    • 2
  • F. Agosti
    • 3
    • 4
  • V. Cappiello
    • 1
  • A. Sartorio
    • 2
    • 3
    • 4
  • A. Spada
    • 1
    Email author
  1. 1.Institute of Endocrine SciencesUniversity of Milan, Ospedale Maggiore IRCCSMilanoItaly
  2. 2.3rd Division of Metabolic DiseasesIstituto Auxologico Italiano, IRCCSMilan and VerbaniaItaly
  3. 3.Laboratory for Experimental Endocrinological ResearchIstituto Auxologico Italiano, IRCCSMilanItaly
  4. 4.VerbaniaItaly

Personalised recommendations